Clinical trial
Combined Radiotherapy and Intravenous Steroids for Early Progressive Thyroid Eye Disease
NCT02339142 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Combined Radiotherapy and Intravenous Steroids for Early Progressive Thyroid Eye Disease
- Lead sponsor
- University of British Columbia
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- January 31, 2015
- Completion date
- December 31, 2019
- Enrollment
- 100 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.